A phase II, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of MLTA3698A in combination with a disease-modifying anti-rheumatic drug (DMARD) compared with adalimumab in combination with a DMARD in patients with active rheumatoid arthritis (2011 - Present)

A multi-center, continuation trial of belimumab (HGS 1006, LymphoStat-BTM), a fully human monoclonal anti-BLyS antibody, in subjects with systemic lupus erythematosus (SLE) who completed the phase 3 protocol HGS1006-C1056 in the United States (2010 - Present)